Latest news with #SME
News18
3 hours ago
- Business
- News18
Influx Healthtech IPO Receives Over 201.3x Subscription On Final Day Of Bidding; Check GMP Today
The GMP of the Influx Healthtech IPO is 18.75%, indicating strong listing gains for investors. Influx Healthtech IPO Day 3: The initial public offering of Influx Healthtech Ltd has been closed today, Friday, June 20. The IPO has received a strong response from investors. Till 5:00 pm on the final day of bidding on Friday, the Rs 55.63-crore SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The three-day IPO was opened on Wednesday, June 18. It received a 5.89 times subscription on Day 1 on Wednesday and a 25.47 times subscription on Day 2. Influx Healthtech IPO Price The price of the Influx Healthtech IPO has been fixed at Rs 96 apiece. Influx Healthtech IPO Lot Size The minimum lot size is 1,200 shares, requiring a retail investment of Rs 1,15,200. For NIIs, the minimum is 2 lots (2,400 shares) at Rs 2,30,400. According to market observers, the GMP of the Influx Healthtech IPO is 18.75%, indicating strong listing gains for investors. The 18.75% GMP is significantly lower than the 39.58% premium recording in the morning. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. The shares of Influx Healthtech Ltd will be listed on the NSE SME on June 25. The Eppeltone Engineers IPO is a book-built issue worth Rs 55.63 crore, comprising a fresh issue of 46.94 lakh equity shares worth Rs 45.07 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. The IPO opened for subscription on June 18, 2025, and will close on June 20, 2025. Share allotment is likely to be finalised on June 23, with the listing expected on the NSE SME platform on June 25, 2025. The price band is set at Rs 96 per share. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.
Economic Times
7 hours ago
- Business
- Economic Times
BSE introduces AI tool to speed up SME IPO document checks
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel BSE has launched a new generative AI tool to help speed up the initial checking process of SME IPO documents. Right now, vetting these documents can take several days or even weeks — but with this new tool, experts say the process could be reduced to just 30–40 per a recent circular, merchant bankers — who handle IPO filings — will be given access to a special folder where they can upload draft IPO documents. The AI tool will scan the draft and highlight any sections that need improvement or corrections before final submission."This tool is meant to improve the SME listing experience," said BSE. The AI tool will be accessed through a secure file transfer system (SFTP) and will serve as a pre-check mechanism, helping bankers make the draft more compliant before officially filing it with the its inception, the BSE SME platform has listed around 600 companies and helped raise nearly Rs 9,500 crore. The combined market value of these listed SMEs is over Rs 68,500 you include companies that have shifted from SME to the main board, the total jumps to about Rs 1.73 lakh crore. Around 200 firms have made that move so Joshi, founder of MMJC and Associates, called the move a 'progressive shift.' He said that while document vetting usually took a week, this AI tool could do it in under an hour. However, this facility is just for initial advice. The BSE will still review the final filing in full before giving official read: Sebi proposes 5-point AI rulebook for securities market. Check details This AI tool won't replace BSE's review, but it will help merchant bankers catch and fix issues earlier — making the IPO filing process smoother and faster.
Time of India
8 hours ago
- Business
- Time of India
BSE introduces AI tool to speed up SME IPO document checks
BSE has launched a new generative AI tool to help speed up the initial checking process of SME IPO documents. Right now, vetting these documents can take several days or even weeks — but with this new tool, experts say the process could be reduced to just 30–40 minutes. As per a recent circular, merchant bankers — who handle IPO filings — will be given access to a special folder where they can upload draft IPO documents. The AI tool will scan the draft and highlight any sections that need improvement or corrections before final submission. "This tool is meant to improve the SME listing experience," said BSE. The AI tool will be accessed through a secure file transfer system (SFTP) and will serve as a pre-check mechanism, helping bankers make the draft more compliant before officially filing it with the exchange. Since its inception, the BSE SME platform has listed around 600 companies and helped raise nearly Rs 9,500 crore. The combined market value of these listed SMEs is over Rs 68,500 crore. If you include companies that have shifted from SME to the main board, the total jumps to about Rs 1.73 lakh crore. Around 200 firms have made that move so far. Makarand Joshi, founder of MMJC and Associates, called the move a 'progressive shift.' He said that while document vetting usually took a week, this AI tool could do it in under an hour. However, this facility is just for initial advice. The BSE will still review the final filing in full before giving official approval. Also read: Sebi proposes 5-point AI rulebook for securities market. Check details This AI tool won't replace BSE's review, but it will help merchant bankers catch and fix issues earlier — making the IPO filing process smoother and faster.
Mint
9 hours ago
- Business
- Mint
Aakaar Medical Technologies IPO day 1: GMP, subscription status, price band, other details of NSE SME IPO
Aakaar Medical Technologies IPO: The initial public offering (IPO) of medical aesthetic company Aakaar Medical Technologies opened for subscription on Friday, June 20. The ₹ 25.64 crore book building issue is entirely a fresh issue of 35.62 lakh shares. On the first day of subscription, the NSE SME IPO saw a tepid response from retail investors. By 4 PM on Friday, the first day of subscription, the issue had been subscribed to 31 per cent, with the retail portion subscribed to 25 per cent, the segment reserved for non-institutional investors (NIIs) subscribed to 39 per cent, and the segment reserved for qualified institutional buyers subscribed to 33 per cent. 1. Aakaar Medical Technologies IPO GMP: According to market sources, the latest grey market premium (GMP) of Aakaar Medical Technologies shares was nil. This means the stock could list at par with the issue price. 2. Aakaar Medical Technologies IPO date: The SME IPO opened for subscription on Friday, June 20, and will conclude on Tuesday, June 24. 3. Aakaar Medical Technologies IPO price: The price band of the public issue has been fixed at ₹ 68 to ₹ 72 per equity share. 4. Aakaar Medical Technologies IPO size: The company intends to raise ₹ 25.64 crore from the issue, which it will use to fund working capital requirements and for general corporate purposes. 5. Aakaar Medical Technologies IPO lot size: Bidders can apply in lots, and one lot of the NSE SME IPO comprises 1,600 company shares. 6. Aakaar Medical Technologies IPO reservation: As much as 47 per cent of the net issue is reserved for QIBs, while 33 per cent of the net issue is reserved for retail investors, and a little over 14 per cent of the issue is reserved for NIIs. 7. Aakaar Medical Technologies IPO allotment date: The IPO is closing on Tuesday, June 24, so as per SEBI's listing rules, the company is expected to finalise the share allotment on Wednesday, June 25. Successful bidders can expect shares of the company in their demat accounts on Thursday, June 26, and bidders who fail to get the allocation may get a refund on the same day. 8. Aakaar Medical Technologies IPO book-running lead manager and registrar: Indorient Financial Services Limited is the book-running lead manager, while Bigshare Services Private Limited is the registrar for the issue. 9. Aakaar Medical Technologies IPO listing: As per SEBI's T+3 rule of IPO listing, the SME IPO is proposed for listing on the NSE SME on Friday, June 27. 10. Aakaar Medical Technologies business overview: According to the company's RHP, Aakaar Medical Technologies is a medical aesthetic company dealing in a wide range of aesthetics and specialised cosmetic products and devices. The company's profit after tax (PAT) for FY23 stood at ₹ 2.15 crore, which rose to ₹ 2.87 crore in FY24 and ₹ 6.04 crore in FY25. Revenue from operations for FY23, FY24 and FY25 stood at ₹ 32.78 crore, ₹ 46.11 crore and ₹ 61.58 crore, respectively. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.
Business Times
15 hours ago
- Business
- Business Times
Funding Societies partners VPBank to facilitate SME financing access in Vietnam
[SINGAPORE] Digital finance platform Funding Societies on Friday (Jun 20) entered a commercial agreement of an undisclosed value with Vietnam Prosperity Joint Stock Commercial Bank (VPBank) to help small and medium-sized enterprises (SMEs) access financing from the lender. The partnership aims to address financial gaps for SMEs in Vietnam, which were estimated to stand at US$24 billion or around 2.11 times the current lending level for such businesses as at August 2024, financial data provider FiinGroup indicated. Kelvin Teo, co-founder and group chief executive of Funding Societies, said: 'We bridge the SME financing gap by reaching, assessing and channeling viable SME borrowers with one of Vietnam's most trusted banks.' Through a loan channeling arrangement, Funding Societies will connect potential borrowers to VPBank via its newly launched financing application, SmartSME, to facilitate the process of obtaining financing. The fintech startup will draw on its expertise from prior ventures in countries across South-east Asia – including Singapore, Malaysia and Indonesia – to identify eligible SMEs that are seeking financing and to bring them onboard the SmartSME platform, which was launched on Tuesday. It will screen potential borrowers for eligibility by using its proprietary artificial intelligence-driven credit technology to assess SMEs' loan repayment abilities to mitigate risks, as the SmartSME platform offers unsecured loans. Funding Societies said the collaboration is expected to enhance opportunities for the private sector to access capital resources. This is in line with the Vietnam government's newly issued directive, Resolution 68, that outlines the role of the private sector as a key driver of growth for the nation.
